This HTML5 document contains 51 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q69835594
rdf:type
wikibase:Item
schema:description
scientific article published on 01 February 1985 im Februar 1985 veröffentlichter wissenschaftlicher Artikel artículu científicu espublizáu en febreru de 1985 наукова стаття, опублікована в лютому 1985 wetenschappelijk artikel
p:P577
wds:Q69835594-3A2C93EB-FD07-4EAE-B28A-91ECE31428B8
wdt:P577
1985-02-01T00:00:00Z
p:P2093
wds:Q69835594-F960147B-ED2A-4D86-88E9-A9405D923C85 wds:Q69835594-AE2D78CF-AB45-4009-842D-C09A42B83D7F wds:Q69835594-7898F756-B580-435F-97B3-B0AAC3186FF8 wds:Q69835594-56A2E105-1BA6-4C8A-8D52-DAF8FC59207D wds:Q69835594-1EC044E3-5A3A-4258-B6C4-80F16330A03A wds:Q69835594-23C1CD72-6BA9-4F79-8421-BD02338DFE36 wds:Q69835594-081B6321-CB6B-45EA-A55F-801334065960
wdt:P2093
N Duez A Lacave T Splinter G Blijham H Bleiberg J Wils O Dalesio
rdfs:label
Phase II study of epirubicin in advanced adenocarcinoma of the pancreas Phase II study of epirubicin in advanced adenocarcinoma of the pancreas Phase II study of epirubicin in advanced adenocarcinoma of the pancreas
skos:prefLabel
Phase II study of epirubicin in advanced adenocarcinoma of the pancreas Phase II study of epirubicin in advanced adenocarcinoma of the pancreas Phase II study of epirubicin in advanced adenocarcinoma of the pancreas
schema:name
Phase II study of epirubicin in advanced adenocarcinoma of the pancreas Phase II study of epirubicin in advanced adenocarcinoma of the pancreas Phase II study of epirubicin in advanced adenocarcinoma of the pancreas
p:P1476
wds:Q69835594-812D4361-48FC-4114-996C-F480D41B11F6
wdt:P1476
Phase II study of epirubicin in advanced adenocarcinoma of the pancreas
p:P304
wds:Q69835594-60C75C4E-5CD7-4C5B-9B01-DE45713DF95E
wdt:P304
191-194
p:P31
wds:Q69835594-EA95DA69-3B6C-4C8E-9B02-CD208A465296
wdt:P31
wd:Q13442814
p:P921
wds:Q69835594-6F6E4B32-662D-4EC2-8226-AFD6A4C4F42B
wdt:P921
wd:Q356033
p:P698
wds:Q69835594-002BA696-9A8E-4A90-AF09-B176972D2F90
wdtn:P698
n10:3857181
wdt:P698
3857181
p:P1433
wds:Q69835594-ED209706-DCB1-4216-8314-53A98CA4A57F
wdt:P1433
wd:Q27710832
p:P433
wds:Q69835594-E90873E7-B58F-4B4D-8016-24D111CE570E
p:P478
wds:Q69835594-B278CA32-445D-4593-86CA-877CE914E1E0
wdt:P433
2
wdt:P478
21
p:P356
wds:Q69835594-3BCA8870-31ED-41E9-B8C7-C6C29A1BF415
wdtn:P356
n12:0277-5379(85)90172-5
wdt:P356
10.1016/0277-5379(85)90172-5